TEVA
Teva Pharmaceutical Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.2% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 149 | +7 | 367.15M | $12.41B | +9 | −3 |
| Q1 2026 | 146 | +3 | 327.68M | $9.78B | +10 | −8 |
| Q4 2025 | 144 | -1 | 326.44M | $10.18B | +3 | −3 |
| Q3 2025 | 23 | 0 | 176.53M | $3.56B | +1 | −2 |
| Q2 2025 | 21 | 0 | 197.53M | $3.31B | n/a | n/a |
| Q1 2025 | 18 | -3 | 84.56M | $1.30B | n/a | −3 |
| Q4 2024 | 21 | -1 | 89.79M | $1.98B | n/a | −1 |
| Q3 2024 | 21 | +2 | 78.93M | $1.23B | +2 | n/a |
| Q2 2024 | 19 | n/a | 61.88M | $1.01B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 58.14M | n/a | $974.35M | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasif) | 54.32M | n/a | $910.38M | 0.0% | n/c | 1 | SEC ↗ ×20 |
| 3 | State Street Global Advisors ✦ (pasif) | 17.29M | -0.2% | $289.73M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Duquesne Family Office ✦ | 15.97M | +7.3% | $267.64M | 6.8% | ▲ Add | 4 | SEC ↗ |
| 5 | Glenview Capital ✦ | 15.82M | +7.1% | $265.21M | 7.5% | ▲ Add | 5 | SEC ↗ |
| 6 | Viking Global Investors ✦ | 11.68M | +15.4% | $195.78M | 0.6% | ▲ Add | 4 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasif) | 9.63M | +4.7% | $160.25M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Greenlight Capital (DME Capital) ✦ | 3.78M | +565.0% | $63.33M | 2.7% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 3.16M | -40.5% | $52.91M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 2.21M | -22.4% | $37.09M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 11 | Norges Bank ✦ (pasif) | 1.86M | -27.9% | $31.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | Millennium Management ✦ | 1.10M | -80.0% | $18.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasif) | 885.45K | n/a | $14.84M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 534.00K | +10.3% | $8.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 461.12K | +13.7% | $7.73M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 319.89K | +133.8% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 121.82K | +50.1% | $2.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | ARK Investment Management ✦ | 120.87K | +33.9% | $2.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 89.20K | -4.3% | $1.49M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 26.03K | +8.7% | $436,245 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 21 | Wellington Management ✦ | 17.53K | -87.3% | $293,870 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 646 pemegang, 666.61M saham, $16.70B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.52K lbr · $98,841
Director · 367.60K lbr · $14.36M
Officer · 4.50K lbr · $174,221
Officer · 314 lbr · $12,153
Officer · 2.50K lbr · $94,077
Director · 415 lbr · $15,459
Officer · 6.95K lbr · $261,224
Officer · 18.60K lbr · $680,291
Director · 17 lbr · $593
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi